UnitedHealth Group (NYSE:UNH) Given New $400.00 Price Target at KeyCorp

UnitedHealth Group (NYSE:UNH) had its price objective lowered by KeyCorp from $450.00 to $400.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the healthcare conglomerate’s stock.

A number of other research analysts also recently commented on the stock. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a report on Thursday, May 15th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Robert W. Baird reduced their price objective on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 14th. Finally, TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $439.17.

UnitedHealth Group Stock Up 0.8%

UNH opened at $304.27 on Monday. The firm has a 50-day simple moving average of $426.60 and a two-hundred day simple moving average of $490.74. UnitedHealth Group has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a market capitalization of $276.01 billion, a PE ratio of 19.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the company earned $6.91 EPS. Analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley acquired 86,700 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.33% of the stock is owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors have recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $6,375,744,000. GAMMA Investing LLC grew its holdings in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC purchased a new stake in shares of UnitedHealth Group during the first quarter valued at $3,846,764,000. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $1,914,740,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.